Yoga to Reduce Cancer Fatigue

Inclusion criteria

• Potential subjects must have had histologically or cytologically confirmed breast cancer. This includes, but is not limited to: breast cancer-in situ; ductal carcinoma in situ; lobular carcinoma in situ; cystosarcoma phyllodes; inflammatory breast carcinoma; invasive breast carcinoma; and breast cancer not otherwise specified; cancer must be stage 0 through stage III.
• Treatment completion within the past calendar year.
• Age ≥ 18 years. While breast cancer can occur in the pediatric population, the pediatric population is best served by trials specifically designed for their age group.
• Life expectancy of greater than 1 year.
• Karnofsky ≥ 60%; see Appendix A.
• Women of childbearing potential are eligible for this study.
• Pregnant women are eligible for this study pending a doctor's note.
• The ability to understand and complete the study questionnaires.
• Ability to understand and the willingness to sign a written informed consent document.

Exclusion criteria

• Patients who have not recovered from adverse events due to agents administered more than 4 weeks earlier.
• Patients with known metastasis.
• Patients who are actively participating in a yoga class.
• Known uncontrolled intercurrent illness including, but not limited to, ongoing or active infection, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia, or psychiatric illness/social situations that would compromise subject health during yoga.